Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide Riboside for Small Fiber Neuropathy
NCT03912220Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Sep 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in small fiber neuropathy (SFN) comparing Nicotinamide Riboside with Placebo (2 arms). Primary endpoints: Denervation of Skin at 2 days and Reinnervation of Skin at 3 months. Started Sep 2020; status: completed.
02
Drugs
nicotinamide riboside
03
Conditions
small fiber neuropathy (SFN)
Beyond the preview
Go deeper on NCT03912220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03912220.